Adapthealth Corp
$ 9.08
-2.68%
26 Feb - close price
- Market Cap 1,263,509,000 USD
- Current Price $ 9.08
- High / Low $ 9.35 / 8.84
- Stock P/E 16.96
- Book Value 11.46
- EPS 0.55
- Next Earning Report 2026-05-12
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.03 %
- ROE -0.04 %
- 52 Week High 11.53
- 52 Week Low 7.11
About
AdaptHealth Corp. The company is headquartered in Plymouth Meeting, Pennsylvania.
Analyst Target Price
$13.00
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-02-24 | 2025-11-04 | 2025-08-05 | 2025-05-05 | 2025-02-25 | 2024-11-05 | 2024-08-06 | 2024-05-07 | 2024-02-27 | 2023-11-07 | 2023-08-08 | 2023-05-09 |
| Reported EPS | 0.2689 | 0.16 | 0.2179 | -0.0535 | 0.4194 | 0.1533 | 0.13 | -0.02 | -1.91 | 0.42 | 0.09 | 0.11 |
| Estimated EPS | 0.3604 | 0.24 | 0.16 | 0.04 | 0.281 | 0.17 | 0.16 | 0.05 | 0.18 | 0.19 | 0.1 | 0.08 |
| Surprise | -0.0915 | -0.08 | 0.0579 | -0.0935 | 0.1384 | -0.0167 | -0.03 | -0.07 | -2.09 | 0.23 | -0.01 | 0.03 |
| Surprise Percentage | -25.3885% | -33.3333% | 36.1875% | -233.75% | 49.2527% | -9.8235% | -18.75% | -140% | -1161.1111% | 121.0526% | -10% | 37.5% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-12 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | 0.0514 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: AHCO
2026-02-26 01:52:01
A federal judge in Pennsylvania has rejected a motion to dismiss a securities class action against AdaptHealth, clearing the way for a proposed $12 million settlement to proceed. The settlement, covering alleged misconduct between November 2019 and July 2021, is considered financially insignificant for AdaptHealth but highlights underlying concerns about misrepresentation of organic growth and billing practices. While the settlement resolves one issue, it may trigger further lawsuits and regulatory scrutiny, particularly regarding potential violations of Medicare and Medicaid billing regulations.
2026-02-25 19:59:00
Halper Sadeh LLC, an investor rights law firm, is investigating whether officers and directors of AdaptHealth Corp. (NASDAQ: AHCO) breached their fiduciary duties to shareholders. The firm encourages long-term shareholders to contact them to discuss potential corporate governance reforms, recovery of funds, or other benefits. Shareholder involvement can lead to improved company policies and enhanced shareholder value.
2026-02-25 10:52:01
AdaptHealth Corp. has released its financial results for the fourth quarter and full-year 2025, reporting a net revenue of $3.24 billion for the full year and a net loss of $70.8 million, impacted by a goodwill impairment charge. Despite the financial decline, the company achieved patient census records, expanded geographically, and reduced its debt by $250 million in 2025. AdaptHealth also provided positive financial guidance for 2026, anticipating net revenue between $3.44 billion and $3.51 billion.
2026-02-24 21:54:11
AdaptHealth Corp. has released its 2025 Form 10-K report, revealing a total net revenue of $3,244.9 million, a 0.5% decrease from the previous year, and a net loss of $66.0 million due to goodwill impairment and increased costs. The company is strategically managing its portfolio through dispositions and acquisitions, focusing on technological advancements, and aiming to reduce debt and maintain strong liquidity. AdaptHealth faces significant operational, financial, cybersecurity, regulatory, and market risks, along with challenges from a competitive landscape and integration risks associated with its growth strategy.
2026-02-24 20:54:11
AdaptHealth Corp.'s (AHCO) stock plummeted 16.4% after its Q4 2025 report revealed a significant loss of $0.76 per share, far missing analyst expectations for a profit, despite beating revenue forecasts. This poor profitability, marked by a negative operating margin and missed adjusted EBITDA, has led to increased stock volatility. The company's shares are currently trading 24.5% below its 52-week high, indicating a substantial negative market reaction to the earnings results.
2026-02-24 11:54:11
AdaptHealth Corp. announced its financial results for the fourth quarter and full fiscal year ended December 31, 2025, revealing a net revenue decrease of 0.7% for the full year and 1.2% for the fourth quarter. The company, a national leader in healthcare-at-home solutions, also provided its financial guidance for fiscal year 2026, including projected net revenue of $3.22 billion to $3.31 billion and Adjusted EBITDA of $490 million to $560 million. Management highlighted 2025 as a year of significant transition, marked by operational model transformation and debt reduction, positioning AdaptHealth for sustained growth.
